Literature DB >> 20888310

[Treatment of pneumococcal meningitis with dexamethasone].

A Felipe Rucián1, G García Del Cerro, F Coll Usandizaga, M Tobeña Rué, X Martínez Gómez, F A Moraga-Llop.   

Abstract

Our aim was two compare two different dexamethasone administration schedules in pneumococcal meningitis: short course (48h) and long course (96h) treatment. We diagnosed 18 pneumococcal meningitis treated with the two different schedules. We found a statistically significant longer duration of primary fever in patients who received dexamethasone for two days. We found no differences in the appearance of secondary fever, or in the development of severe neurological handicaps, or death between the two groups. We conclude that they are no significant differences between the two treatment schedules and that there is a need for developing early prognostic markers and adjuvant therapies that improve the outcome of patients with pneumococcal meningitis.
Copyright © 2010 Asociación Española de Pediatría. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20888310     DOI: 10.1016/j.anpedi.2010.08.013

Source DB:  PubMed          Journal:  An Pediatr (Barc)        ISSN: 1695-4033            Impact factor:   1.500


  1 in total

1.  Dexamethasone treatment reverses cognitive impairment but increases brain oxidative stress in rats submitted to pneumococcal meningitis.

Authors:  Tatiana Barichello; Ana Lucia B Santos; Cintia Silvestre; Jaqueline S Generoso; Andreza L Cipriano; Fabricia Petronilho; Felipe Dal-Pizzol; Clarissa M Comim; João Quevedo
Journal:  Oxid Med Cell Longev       Date:  2011-11-21       Impact factor: 6.543

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.